Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer

By Papadavid Evangelia   Stratigos Alexandros J   Falagas Matthew E  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. : 1743-1755

Informa Healthcare

Access to resources Recommend Favorite

Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer

By Patel Sharmila   Player Mark R  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 12, 2008-12 ,pp. : 1865-1882

Informa Healthcare

Access to resources Recommend Favorite

Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors

By Muller Alexander J   Malachowski William P   Prendergast George C  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 831-849

Informa Healthcare

Access to resources Recommend Favorite

Small-molecule inhibitors of histone deacetylase for the treatment of cancer and non-cancer diseases: a patent review (2011 – 2013)

By Valente Sergio   Mai Antonello  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 4, 2014-04 ,pp. : 401-415

Informa Healthcare

Access to resources Recommend Favorite

The Role of Topical Immune Response Modifiers in Skin Cancer

By Woodmansee Courtney   Pillow Jessica   Skinner Robert B.  

Drugs, Vol. 66, Iss. 13, 2006-01 ,pp. : 1657-1664

Adis International

Access to resources Recommend Favorite